Home LiteratureArticle Details
PMID: 15308697 Published · ppublish English Journal Article

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.

Journal of virology ·Vol. 78 ·No. 17 ·2004-09-00 ·Pages 9007-15

Giroglou T, Cinatl J, Rabenau H, Drosten C, Schwalbe H, Doerr HW, von Laer D

Abstract

The worldwide outbreak of severe acute respiratory syndrome (SARS) was shown to be associated with a novel coronavirus (CoV) now called SARS CoV. We report here the generation of SARS CoV S protein-pseudotyped murine leukemia virus (MLV) vector particles. The wild-type S protein pseudotyped MLV vectors, although at a low efficiency. Partial deletion of the cytoplasmic tail of S dramatically increased infectivity of pseudotypes, with titers only two- to threefold lower than those of pseudotypes generated in parallel with the vesicular stomatitis virus G protein. S-pseudotyped MLV particles were used to analyze viral tropism. MLV(SARS) pseudotypes and wild-type SARS CoV displayed similar cell types and tissue and host restrictions, indicating that the expression of a functional receptor is the major restraint in permissiveness to SARS CoV infection. Efficient gene transfer could be detected in Vero and CaCo2 cells, whereas the level of gene marking of 293T, HeLa, and HepG2 cells was only slightly above background levels. A cat cell line and a dog cell line were not susceptible. Interestingly, PK-15, a porcine kidney cell line, and primary porcine kidney cells were also highly permissive for SARS S pseudotypes and wild-type SARS CoV. This finding suggests that swine may be susceptible to SARS infection and may be a source for infection of humans. Taken together, these results indicate that MLV(SARS) pseudotypes are highly valuable for functional studies of viral tropism and entry and, in addition, can be a powerful tool for the development of therapeutic entry inhibitors without posing a biohazard to human beings.

MeSH Terms
Animals Antibodies, Viral/immunology Cats Cell Line, Tumor Cells, Cultured Dogs Genetic Engineering Genetic Vectors/genetics,physiology Humans Immune Sera/immunology Leukemia Virus, Murine/genetics,immunology,physiology Membrane Glycoproteins/genetics,immunology,metabolism Neutralization Tests Organ Specificity SARS Virus/classification,genetics,immunology,physiology Sequence Deletion Severe Acute Respiratory Syndrome/immunology,transmission,virology Species Specificity Spike Glycoprotein, Coronavirus Swine/virology Viral Envelope Proteins/genetics,immunology,metabolism Zoonoses/transmission,virology
Chemicals
Antibodies, Viral G protein, vesicular stomatitis virus Immune Sera Membrane Glycoproteins Spike Glycoprotein, Coronavirus Viral Envelope Proteins spike glycoprotein, SARS-CoV spike protein, mouse hepatitis virus
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Giroglou Tsanan
Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt University Medical School, Frankfurt, Germany.
Cinatl Jindrich
Rabenau Holger
Drosten Christian
Schwalbe Harald
Doerr Hans Wilhelm
von Laer Dorothee
References (43)
43 references, click to expand
  1. Production of high-titer helper-free retroviruses by transient transfection.
    Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8392-6 PMID: 7690960
  2. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.
    J Virol. 1993 May;67(5):2824-31 PMID: 8474176
  3. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.
    J Virol. 1997 Jun;71(6):4815-20 PMID: 9151877
  4. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.
    Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8640-5 PMID: 9238030
  5. Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents.
    Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10803-8 PMID: 9380714
  6. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.
    J Virol. 1998 Feb;72(2):1224-34 PMID: 9445022
  7. High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol.
    Hum Gene Ther. 1998 Jan 20;9(2):225-34 PMID: 9472782
  8. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.
    J Virol. 1998 Apr;72(4):3155-60 PMID: 9525641
  9. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism.
    J Virol. 1998 Dec;72(12):9628-36 PMID: 9811696
  10. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.
    J Virol. 1998 Dec;72(12):9873-80 PMID: 9811723
  11. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus.
    J Virol. 1999 Jul;73(7):6114-6 PMID: 10364368
  12. Targeted recombination demonstrates that the spike gene of transmissible gastroenteritis coronavirus is a determinant of its enteric tropism and virulence.
    J Virol. 1999 Sep;73(9):7607-18 PMID: 10438851
  13. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
    Virology. 1999 Aug 15;261(1):70-8 PMID: 10441556
  14. Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier.
    J Virol. 2000 Feb;74(3):1393-406 PMID: 10627550
  15. Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors.
    Mol Ther. 2000 Nov;2(5):435-45 PMID: 11082317
  16. Coronavirus spike proteins in viral entry and pathogenesis.
    Virology. 2001 Jan 20;279(2):371-4 PMID: 11162792
  17. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
    J Virol. 2002 Feb;76(3):1488-95 PMID: 11773421
  18. The angiotensin-converting enzyme gene family: genomics and pharmacology.
    Trends Pharmacol Sci. 2002 Apr;23(4):177-83 PMID: 11931993
  19. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Hum Gene Ther. 2002 May 1;13(7):803-13 PMID: 11975847
  20. Just the beginning: novel functions for angiotensin-converting enzymes.
    Curr Biol. 2002 Oct 29;12(21):R745-52 PMID: 12419208
  21. Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme.
    FEBS Lett. 2002 Dec 4;532(1-2):107-10 PMID: 12459472
  22. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.
    J Virol. 2003 Mar;77(5):2866-72 PMID: 12584310
  23. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
    J Exp Med. 2003 Mar 3;197(5):633-42 PMID: 12615904
  24. Coronavirus as a possible cause of severe acute respiratory syndrome.
    Lancet. 2003 Apr 19;361(9366):1319-25 PMID: 12711465
  25. Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
    N Engl J Med. 2003 May 15;348(20):1967-76 PMID: 12690091
  26. A novel coronavirus associated with severe acute respiratory syndrome.
    N Engl J Med. 2003 May 15;348(20):1953-66 PMID: 12690092
  27. SARS-associated coronavirus.
    N Engl J Med. 2003 May 15;348(20):1948-51 PMID: 12748314
  28. Aetiology: Koch's postulates fulfilled for SARS virus.
    Nature. 2003 May 15;423(6937):240 PMID: 12748632
  29. Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
    Science. 2003 May 30;300(5624):1394-9 PMID: 12730500
  30. The Genome sequence of the SARS-associated coronavirus.
    Science. 2003 May 30;300(5624):1399-404 PMID: 12730501
  31. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.
    Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6 PMID: 12761383
  32. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
    Lancet. 2003 Jul 26;362(9380):263-70 PMID: 12892955
  33. Treatment of SARS with human interferons.
    Lancet. 2003 Jul 26;362(9380):293-4 PMID: 12892961
  34. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.
    Science. 2003 Oct 10;302(5643):276-8 PMID: 12958366
  35. Virology: SARS virus infection of cats and ferrets.
    Nature. 2003 Oct 30;425(6961):915 PMID: 14586458
  36. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.
    Nature. 2003 Nov 27;426(6965):450-4 PMID: 14647384
  37. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  38. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.
    Virology. 1982 Jun;119(2):358-71 PMID: 6281979
  39. Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus.
    Virology. 1983 Dec;131(2):296-307 PMID: 6318433
  40. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments.
    J Virol. 1985 Dec;56(3):904-11 PMID: 2999443
  41. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion.
    J Virol. 1985 Dec;56(3):912-20 PMID: 2999444
  42. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
    J Virol. 1991 Mar;65(3):1202-7 PMID: 1847450
  43. Generation of high-titer pseudotyped retroviral vectors with very broad host range.
    Methods Cell Biol. 1994;43 Pt A:99-112 PMID: 7823872
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-09-00
Pages
9007-15
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC506966
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com